Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on October 11th, 2017 by Christy J. Wilson in Pharma R&D
Researchers are always looking for new ways to attack cancer, and the scientists at Boston-based biotech start-up Rubius Therapeutics have happened upon an unexpected ally: the red blood cell.
Posted on February 17th, 2017 by Betsy Davis in Pharma R&D
StemCiTerra, LLC is a small American start-up with a mission to make cancer treatments more effective. The company’s President & CSO, Lyubov Ostrovska, Ph.D., chats about their research. Continue reading “Start-Up Spotlight: StemCiTerra, LLC” »
Posted on June 21st, 2016 by Christy J. Wilson in Pharma R&D
Biomarker-based patient selection for clinical trials, a hallmark of precision medicine, is gaining traction. On Monday June 6, a team of researchers reported at the American Society of Clinical Oncology annual meeting and in an online paper in JAMA Oncology that biomarker selection results in better outcomes in Phase l trials. Continue reading “Advancing the Development and Clinical Use of Biomarkers” »